Tau-MEDICAL Co., Ltd.
PrivateLast Round
Series C
Jun 4, 2024
Est. Valuation
$125M
Total Funding Raised
$36.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tau-MEDICAL Co., Ltd. operates in Healthcare & Life Sciences and is based in Yangsan. Its latest recorded funding round was a Series C round in June 2024.
Tau-MEDICAL Co., Ltd. is a medical technology company that develops minimally invasive cardiovascular devices for the treatment of structural heart diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tau-MEDICAL Co., Ltd. Comparables
Compare Tau-MEDICAL Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TRiCares | 84% | |
| CroíValve | 84% | |
| VDyne | 81% |
For institutional investors. Book with your work email.
Tau-MEDICAL Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 4, 2024 | ||||
| Series A | Sep 15, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tau-MEDICAL Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Smilegate Investment | Series A, Series C, Series B |
| STASSETS INVESTMENT | VC Round |
| Stonebridge Ventures | Series C, Series B |
| Yuanta Investment | Series A |
| Korea Development Bank | Series C |
| We Ventures | Series C, Series B |
| K-Bridge Investment | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 49% MoM, reaching 4K.
- May 14, 2026
Monthly visitors increased 70% MoM.
For institutional investors. Book with your work email.
Tau-MEDICAL Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tau-MEDICAL Co., Ltd.'s valuation, stock price, and market status.
Is Tau-MEDICAL Co., Ltd. a public or private company?
Tau-MEDICAL Co., Ltd. is a private company.
What is the current stock price of Tau-MEDICAL Co., Ltd.?
Tau-MEDICAL Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Tau-MEDICAL Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tau-MEDICAL Co., Ltd. worth (valuation)?
Tau-MEDICAL Co., Ltd.'s valuation is estimated at $125.0M based on funding round data.
Can I buy Tau-MEDICAL Co., Ltd. stock?
Tau-MEDICAL Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tau-MEDICAL Co., Ltd.'s last funding round?
Tau-MEDICAL Co., Ltd.'s most recent funding round was Series C on June 4, 2024.
Who are the main investors in Tau-MEDICAL Co., Ltd.?
Key investors in Tau-MEDICAL Co., Ltd. include Smilegate Investment, STASSETS INVESTMENT, Stonebridge Ventures, Yuanta Investment, Korea Development Bank.
Will Tau-MEDICAL Co., Ltd. IPO soon?
No public IPO plans have been announced for Tau-MEDICAL Co., Ltd..
How can I track Tau-MEDICAL Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Tau-MEDICAL Co., Ltd.'s shares on secondary markets.